Accelerating the Commercialization of the NanovisQ: Taking Injectable Drug Development to the Next Level
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
QATCH Technologies is pioneering the use of acoustofluidic devices to measure viscosity of formulations at very low volumes (5uL). The technology enables formulation developers to optimize formulations early in the drug development process. The company received a $250,000 SRL to fund development of the high-throughput version of their nanovisQ™ instrument.